"Designing Growth Strategies is in our DNA"

Gastrointestinal Therapeutics Market Size, Share & Industry Analysis, By Product Type (Small Molecules/Conventional Drugs and Biologics & Biosimilars), By Therapy Type (Acid Suppression Therapies {Proton Pump Inhibitor (PPI) and Others}, Targeted Therapies {Antibodies, JAK Inhibitors, and Others}, Anti-Inflammatory & Immunomodulators, Antibiotics, Antiemetics, Motility Agents & Secretagogues, and Others), By Route of Administration (Oral, Parenteral, and Others), By Age Group (Pediatrics and Adults), By Application, By Distribution Channel, and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI114337

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 225
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann